1. 2018
  2. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20

    Krasniqi, A., Bialkowska, M., Xavier, C., Van der Jeught, K., Muyldermans, S., Devoogdt, N. & D'Huyvetter, M., 25 Oct 2018, In : New Biotechnology. 45, p. 69-79 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  3. Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety

    Van der Jeught, K., De Koker, S., Bialkowski, L., Heirman, C., Tjok Joe, P., Perche, F., Maenhout, S., Bevers, S., Broos, K., Deswarte, K., Malard, V., Hammad, H., Baril, P., Benvegnu, T., Jaffrès, P-A., Kooijmans, S. A. A., Schiffelers, R., Lienenklaus, S., Midoux, P., Pichon, C. & 2 othersBreckpot, K. & Thielemans, K., 1 Oct 2018, In : ACS Nano. 12, 10, p. 9815-9829 15 p.

    Research output: Contribution to journalArticleResearchpeer-review

  4. Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapy

    Bialkowski, L., Van der Jeught, K., Bevers, S., Tjok Joe, P., Renmans, D., Heirman, C., Aerts, J. L. & Thielemans, K., 1 Aug 2018, In : International Journal of Cancer. 143, 3, p. 686-698 13 p.

    Research output: Contribution to journalArticleResearchpeer-review

  5. 2017
  6. Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of Non-Hodgkin Lymphoma

    Krasniqi, A., D'Huyvetter, M., Xavier, C., Van der Jeught, K., Muyldermans, S., Van Der Heyden, J., Lahoutte, T., Tavernier, J. & Devoogdt, N., Dec 2017, In : Molecular Cancer Therapeutics. 16, 12, p. 2828-2839 12 p.

    Research output: Contribution to journalArticleResearchpeer-review

  7. Adjuvant-Enhanced mRNA Vaccines

    Bialkowski, L., Van der Jeught, K., Renmans, D., van Weijnen, A., Heirman, C., Keyaerts, M., Breckpot, K. & Thielemans, K., 2017, In : Methods in Molecular Biology. 1499, p. 179-191 13 p.

    Research output: Contribution to journalArticleResearchpeer-review

  8. 2016
  9. Theranostic radiolabeled anti-CD20 nanobody for targeted radionuclide therapy of Non-Hodgkin Lymphoma

    Krasniqi, A., Kahkelam Bungwa, M., Xavier, C., Van Der Jeught, K., Muyldermans, S., Lahoutte, T., Tavernier, J., D'Huyvetter, M. & Devoogdt, N., 10 Sep 2016.

    Research output: Unpublished contribution to conferenceUnpublished abstractResearch

  10. Anti-CD20 nanobody based targeted radionuclide therapy of Non-Hodgkin Lymphoma

    Krasniqi, A., Xavier, C., Van Der Jeught, K., Muyldermans, S., Lahoutte, T., Tavernier, J., D'Huyvetter, M. & Devoogdt, N., 27 May 2016.

    Research output: Unpublished contribution to conferenceUnpublished abstractResearch

  11. Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells

    Van Lint, S., Renmans, D., Broos, K., Goethals, L., Maenhout, S., Benteyn, D., Goyvaerts, C., Du Four, S., Van der Jeught, K., Bialkowski, L., Flamand, V., Heirman, C., Thielemans, K. & Breckpot, K., Feb 2016, In : Cancer Immunology Immunotherapy. 4, 2, p. 146-156 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  12. Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours

    Bialkowski, L., van Weijnen, A., Van der Jeught, K., Renmans, D., Daszkiewicz, L., Heirman, C., Stangé, G., Breckpot, K., Aerts, J. L. & Thielemans, K., 2016, In : Scientific Reports - Nature. 6, p. 1-15 15 p., 22509.

    Research output: Contribution to journalArticleResearchpeer-review

Previous 1 2 3 Next

ID: 105553